MAHSC Inaugural Lecture Series: Professor Phillip Monaghan, Professor Rohna Kearney & Professor Ngozi Elaine Edi-Osagie

Join us in a lecture series that celebrate MAHSC Honorary Clinical Chairs in Greater Manchester, hear their professional and personal journey, clinical and research areas, plans for the future with an opportunity to share your questions.

The MAHSC Honorary Clinical Chairs are awarded on an annual basis by The University of Manchester’s Faculty of Biology, Medicine and Health Promotions Committee. They are awarded to individuals from across Greater Manchester who have made a major contribution to their clinical specialty, including excellence in research and education. There are now 86 MAHSC Honorary Clinical Chairs.

12:00-12:30: Professor Rohna Kearney

12:30-13:00: Professor Phillip Monaghan

13:00-13:30: Professor Ngozi Edi-Osagie

Speaker Biographies

Professor Rohna Kearney

Professor Rohna Kearney is a Consultant Urogynaecologist and Hospital Medical Director for Saint Mary’s Managed Clinical Service, Manchester University NHS Trust.

She trained in Ireland, US and UK, completing a research MD on the clinical and radiological pathogenesis of obstetric pelvic floor dysfunction. This research was completed whilst working with Professor John Delancey at the University of Michigan, identifying injuries to the levator ani muscles with MR imaging after vaginal delivery and further research at University College Dublin with Professor Colm O’Herlihy researching obstetric risk factors for the development of these injuries. After completing subspecialty training in urogynaecology at University College London Hospital she commenced a consultant post at Cambridge University Hospital. In 2014 she moved to take up a Consultant post at Saint Mary’s Hospital, Manchester. She was awarded an honorary chair by the University of Manchester in 2025.

In her current leadership roles Professor Kearney is the National Specialty Advisor for NHS England Women’s specialised services CRG and Hospital Medical Director for Saint Mary’s Managed Clinical Service in Manchester which is one of the largest women’s health, genomic medicine and newborn services in the UK providing care for over 16,000 births and a large neonatal, genomic and gynaecology service. She has been a topic lead for prolapse on the NICE NG 123 published in 2019, a clinical representative on the RCOG Women’s Network and is currently a member of the RCOG Scientific Advisory Committee.

Professor Kearney was a co- chief investigator, alongside colleagues from Glasgow Caledonian University, of the TOPSY trial, researching self-management of vaginal pessary for prolapse and is a co-applicant on the PEPPY trial researching the use of pessary as an adjunct to pelvic floor muscle training for prolapse. She supervises PhD students, 3 of which have been awarded NIHR fellowships in the last 4 years. Her current research interests are in postpartum pelvic floor dysfunction, mesh complications, pelvic floor imaging  and pelvic organ prolapse.

Professor Phillip Monaghan
After graduating from the University of Manchester Institute of Science and Technology (UMIST) in Biochemistry with Applied Molecular Biology, Phillip went on to complete a PhD in Molecular Enzymology at the University of Leicester.  He subsequently commenced training in Clinical Biochemistry at Wirral University Teaching Hospital, Alder Hey Hospital and University Hospital of South Manchester.  Phillip has been a Clinical Scientist at The Christie NHS Foundation Trust and more recently The Christie Pathology Partnership (CPP) in Manchester, UK, for the past 16 years, includng a 5-year tenure as Clincal Director of Pathology.  Phillip is currently overseeing the R&I programme for Pathology at CPP.

Phillip is a member of the UK NEQAS Steering Committee for Immunochemistry, and is previous Chair of the National Quality Assurance Advisory Panel (NQAAP) for Chemical Pathology (Chair: 2019-2022) for the Royal Colleage of Pathologists.  Phillip is Chair of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Committee for Clinical and Analytical Performance Specifications (C-CAPS), is Editor-in-Chief for the journal, Annals of Clinical Biochemistry and sits on the Publication and Communications Committee of the Association of Laboratory Medicine.

Special research interests include evidence-based laboratory medicine (test evaluation), biochemical endocrinology, and translational cancer biomarker development. Phillip is Co-Investigator on the VALTIVE clinical trials portfolio for the validation of a novel blood test to guide VEGFi therapy in ovarian cancer and colorectal cancer.  Phillip was awarded the Silver Research Medal from the Royal College of Pathologists in 2012 for his work on serum cortisol measurement using mass spectrometry in Cushing’s syndrome.

Professor Ngozi Edi-Osagie

Ngozi Edi-Osagie is a consultant neonatologist and is also the National Clinical Director for Neonatal care for NHS England with responsibility for promoting high-quality and safe care for babies and their families and supporting the Government’s objective of reducing stillbirths, neonatal deaths, brain injuries, and pre-term births.

Ngozi has broad clinical and leadership experience, having been a clinical lead, a clinical director, and a Clinical head of division of clinical services. She was a Group Associate Medical Director at MFT for 8 years overseeing support for doctors requiring professional support